Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Schizophrenia Research

• Publication date

  2017-06-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2017.06.050PMID 28673752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

  2017cited by this paper
• Categorizing and assessing negative symptoms

  2017cited by this paper
• CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

  2016cited by this paper
• Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia.

  2016cited by this paper
• Association of CTLA4 and CD28 Gene Variants and Circulating Levels of Their Proteins in Patients with Breast Cancer.

  2016cited by this paper
• CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia

  2015cited by this paper
• Odors identification differences in deficit and nondeficit schizophrenia

  2015cited by this paper
• Brain white matter microstructure in deficit and non-deficit subtypes of schizophrenia.

  2015cited by this paper
• Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

  2015cited by this paper
• Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia

  2015cited by this paper
• Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype

  2015cited by this paper
• Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.

  2015cited by this paper
• Is there an association between peripheral immune markers and structural/functional neuroimaging findings?

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation

  2014cited by this paper
• The role of genetic variations of immune system regulatory molecules CD28 and CTLA-4 in schizophrenia.

  2013cited by this paper
• Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia

  2013cited by this paper
• BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample

  2013cited by this paper
• Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.

  2012cited by this paper
• Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

  2012cited by this paper
• Association of CD28 IVS3 +17T/C Polymorphism with Soluble CD28 in Rheumatoid Arthritis

  2011cited by this paper
• The psychiatric symptomatology of deficit schizophrenia: a meta-analysis.

  2010cited by this paper
• Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.

  2010cited by this paper
• The PIP5K2A and RGS4 genes are differentially associated with deficit and non‐deficit schizophrenia

  2007cited by this paper
• Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia.

  2007cited by this paper
• Effect of interleukin‐1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients

  2007cited by this paper
• The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample.

  2006cited by this paper
• Sample size requirements for association studies of gene-gene interaction.

  2002cited by this paper
• Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study.

  2002cited by this paper
• A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation

  2002cited by this paper
• A five-year followup study of deficit and nondeficit schizophrenia.

  2001cited by this paper
• Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia.

  2001cited by this paper
• CD28, CTLA‐4 and their ligands: who does what and to whom?

  2000cited by this paper
• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

  1998cited by this paper
• Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation.

  1998cited by this paper
• A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

  1991cited by this paper
• The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

  1989cited by this paper
• Deficit and nondeficit forms of schizophrenia: the concept.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• The correlation between polymorphism of interleukin 3 receptor alpha Rs6603272 G/T gene with negative symptoms in Bataknese schizophrenia patients

  2026cites this paper
• Relevance of polymorphisms in TLR2/4 genes and their association with plasma cytokines for schizophrenia.

  2026cites this paper
• Association of IL6 Gene Polymorphisms and Neurological Disorders: Insights from Integrated Bioinformatics and Meta-Analysis

  2025cites this paper
• CTLA-4 expression and polymorphisms in Schizophrenia; a systematic review of literature

  2024cites this paper
• Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?

  2024cites this paper
• Molecular-Genetic and Immunological Aspects of the Formation of Psychopathological Symptoms in Schizophrenia

  2023cites this paper
• The association of cytokines genes (IL-6 and IL-10) with the susceptibility to schizophrenia: A systematic review and meta-analysis.

  2023cites this paper
• The Role of Inflammatory Processes in the Etiopathogenesis of Schizophrenia

  2023cites this paper
• Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia

  2022cites this paper
• Identifying crucial biomarkers in peripheral blood of schizophrenia and screening therapeutic agents by comprehensive bioinformatics analysis.

  2022cites this paper
• The relationship between human development and prevalence of deficit schizophrenia: Results from a systematic review and meta-analysis.

  2022cites this paper
• The Role of Cytokines in the Pathogenesis of Schizophrenia

  2021cites this paper
• Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

  2021cites this paper
• IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study

  2019cites this paper
• First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood.

  2019cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning

  2018cites this paper
• [A role of the immune system in the pathogenesis of schizophrenia].

  2018cites this paper
• Assessment of Complement Cascade Components in Patients With Bipolar Disorder

  2018cites this paper
• Human Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases

  2018influential citation
• Association Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population

  2017cites this paper